Ignite Creation Date:
2024-05-06 @ 2:05 PM
Last Modification Date:
2024-10-26 @ 1:25 PM
Study NCT ID:
NCT04211922
Status:
TERMINATED
Last Update Posted:
2024-04-26
First Post:
2019-12-23
Brief Title:
Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib
Sponsor:
Suzhou Zelgen Biopharmaceuticals CoLtd
Organization:
Suzhou Zelgen Biopharmaceuticals CoLtd
Organization Data
Organization:
Suzhou Zelgen Biopharmaceuticals CoLtd
Class:
INDUSTRY
Study ID:
ZGALK002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Suzhou Zelgen Biopharmaceuticals CoLtd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None